What is GenScript?
Founded in 2002 and headquartered in Piscataway, New Jersey, GenScript stands as a premier global biotech entity. The company offers comprehensive life science services and products, operating through four distinct platforms. These include a leading life-science services and products platform designed to provide one-stop solutions for worldwide research communities, a biologics contract development and manufacturing organization (CDMO) platform, an industrial synthetic products platform, and an integrated global cell therapy platform. This multi-faceted approach positions GenScript as a critical partner in scientific advancement and therapeutic development.
How much funding has GenScript raised?
GenScript has raised a total of $67.6M across 1 funding round:
Stock Offering
$67.6M
Stock Issuance/Offering (2015): $67.6M, investors not publicly disclosed
What's next for GenScript?
The recent major strategic investment signals a pivotal phase for GenScript, likely aimed at accelerating its expansion across its core platforms, particularly in the burgeoning fields of biologics manufacturing and cell therapy. This infusion of capital is expected to bolster research and development initiatives, enhance manufacturing capabilities, and potentially facilitate market penetration into new territories. GenScript's strategic positioning and diversified service offerings suggest a continued focus on innovation and market leadership within the global biotechnology landscape.
See full GenScript company page
